期刊文献+

卒中后免疫抑制与辅助性T细胞17变化的研究进展 被引量:1

Stroke-induced immunosuppression and T helper cells 17
下载PDF
导出
摘要 卒中急性期,损伤脑组织释放炎性介质触发炎性级联反应,进一步加重脑损伤,随后卒中可诱导免疫抑制以减轻炎性反应并发挥脑保护的作用。辅助性T细胞(Th) 17及其主要效应因子白细胞介素17A在卒中后增加,进一步促进卒中后炎性反应,加重神经功能缺损。而卒中后免疫抑制相关通路可对Th细胞亚群进行调节,反馈作用于Th17细胞。 In the acute phase of stroke,the injured brain tissue releases inflammatory mediators to trigger the inflammatory cascade reaction.As a result,the Interleukin 17A,a major effector of T helper(Th)cells 17,increases after stroke,further contribute to the inflammatory response and aggravated the neurological deficits.Then the stroke induces immune suppression to suppress the inflammatory response,thus play a role in brain protection.The relevant pathways of post-stroke immunosuppression can regulate the Th cell subset and exert feedback effects on Th17 cells.
作者 徐瑞 马迪 包立阳 冯加纯 Xu Rui;Ma Di;Bao Liyang;Feng Jiachun(Department of Neurology and Center of Neuroscience,t he First Bethune Hospital of Jilin University,Changchun 130000,China)
出处 《中国脑血管病杂志》 CAS CSCD 北大核心 2019年第3期164-168,共5页 Chinese Journal of Cerebrovascular Diseases
关键词 卒中 免疫抑制法 TH17细胞 综述 Stroke Immunosuppression Th17 cells Review
  • 相关文献

参考文献3

二级参考文献43

  • 1Park H,Li Z,Yang XO,et al.A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin17[J].Nat Immunol,2005,6(11):1133-1141.
  • 2Harrington LE,Hatton RD,Mangan PR,et al.Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages[J].Nat Immunol,2005,6(11):1123-1132.
  • 3O′Donnell EF,Saili KS,Koch DC,et al.The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor[J].PLoS One,2010,5(10):e13128.
  • 4Damsker JM,Hansen AM,Caspi RR.Th1 and Th17 cells:adversaries and collaborators[J].Ann N Y Acad Sci,2010,1183:211-221.
  • 5Leipe J,Grunke M,Dechant C,et al.Role of Th17 cells in human autoimmune arthritis[J].Arthritis Rheum,2010,62(10):2876-2885.
  • 6Shah K,Lee WW,Lee SH,et al.Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus[J].Arthritis Res Ther,2010,12(2):R53.
  • 7Balanescu P,Balanescu E,Tanasescu C,et al.T helper 17 cell population in lupus erythematosus[J].Rom J Intern Med,2010,48(3):255-259.
  • 8Fukushima R,Kanamori S,Hirashiba M,et al.Inhibiting the teratogenicity of the immunosuppressant leflunomide in mice by supplementation of exogenous uridine[J].Toxicol Sci,2009,108(2):419-426.
  • 9Dimitrora P,Skapenko A,Schleyerbach R.Immunomodulatory functions of leflunomide:inhibition of Th1 cell activation and promotion of Th2 differentiation[J].Arthritis Rheum,2001,44(9 suppl):S216.
  • 10Liu X,Yang P,Lin X,et al.Inhibitory effect of Cyclosporin A and corticosteroids on the production of IFN-γ and IL-17 by T cells in Vogt-Koyanagi-Harada syndrome[J].Clin Immunol,2009,131(2):333-342.

共引文献3

同被引文献5

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部